Table 3.
Target microorganism | Antimicrobial activity (MIC in μg/mL) |
|||
---|---|---|---|---|
2 | 4 | 5 | Positive control | |
S. aureus ATCC 6538a | 14.0 | 7.2 | 2.8 | 0.25 |
MRSA DA 1a | 14.0 | 7.2 | 2.8 | 0.25 |
MRSA ATCC 43300a | 14.0 | 7.2 | 2.8 | 0.25 |
MRSA GU 34380a | 14.0 | 7.2 | 2.8 | 0.50 |
MRSA GU 34864a | 14.0 | 7.2 | 2.8 | 0.38 |
MRSA GU 3636la | 28.0 | 7.2 | 5.5 | 0.75 |
MRSA GU 53016a | 28.0 | 7.2 | 2.8 | 0.38 |
MRSA GU 52300a | 28.0 | 7.2 | 5.5 | 0.50 |
C. albicans b | >55 | 14.4 | >88 | 25 |
C. neoformans b | >55 | 14.4 | >88 | 25 |
A. niger b | >55 | 14.4 | >88 | 100 |
The positive controls were either
vancomycin
amphotericin B